These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38637125)

  • 21. Construction of an miRNA‑gene regulatory network in colorectal cancer through integrated analysis of mRNA and miRNA microarrays.
    Hu J; Yue X; Liu J; Kong D
    Mol Med Rep; 2018 Dec; 18(6):5109-5116. PubMed ID: 30272280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of an miRNA-mRNA regulatory network in colorectal cancer with bioinformatics methods.
    Su Y; Zhang M; Zhang L; Chen S; Zhang D; Zhang X
    Anticancer Drugs; 2019 Jul; 30(6):588-595. PubMed ID: 30601194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.
    Qi Y; Qi H; Liu Z; He P; Li B
    J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of PVT1 as a biomarker in prostate cancer.
    Liang X; Liu B
    Medicine (Baltimore); 2024 Aug; 103(34):e39406. PubMed ID: 39183420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
    Huang Z; Yang Q; Huang Z
    Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LCN2 and ELANE overexpression induces sepsis.
    Wang T; Han JG; Dong W; Yu YH
    Medicine (Baltimore); 2024 Feb; 103(7):e37255. PubMed ID: 38363924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis.
    Tan Y; Ma Y; Guo S; Lin Y
    Medicine (Baltimore); 2024 Jan; 103(1):e36868. PubMed ID: 38181234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
    Pirim D
    Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
    Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
    Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX9 and IL1A as the Potential Gene Biomarkers of the Oral Cancer.
    Li T; Cheng D; Guo J; Chen H; Zhang S; Bao Y
    Comb Chem High Throughput Screen; 2023; 26(8):1461-1479. PubMed ID: 35762542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
    Liu L; Yin P; Yang R; Zhang G; Wu C; Zheng Y; Wu S; Liu M
    Front Immunol; 2024; 15():1351908. PubMed ID: 38863714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.